Exosomes and Hepatocellular Carcinoma: From Bench to Bedside

被引:101
|
作者
Sasaki, Reina [1 ]
Kanda, Tatsuo [2 ]
Yokosuka, Osamu [1 ]
Kato, Naoya [1 ]
Matsuoka, Shunichi [2 ]
Moriyama, Mitsuhiko [2 ]
机构
[1] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan
[2] Nihon Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol,Itabashi Ku, 30-1 Oyaguchi Kamicho, Tokyo 1738610, Japan
关键词
exosome; hepatocellular carcinoma; microRNA; long noncoding RNA; PROMOTES CELL-PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR; SORAFENIB; EXPRESSION; SERUM; BIOMARKER; MICRORNA; HCC; METASTASIS;
D O I
10.3390/ijms20061406
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As hepatocellular carcinoma (HCC) usually occurs in the background of cirrhosis, which is an end-stage form of liver diseases, treatment options for advanced HCC are limited, due to poor liver function. The exosome is a nanometer-sized membrane vesicle structure that originates from the endosome. Exosome-mediated transfer of proteins, DNAs and various forms of RNA, such as microRNA (miRNA), long noncoding RNA (lncRNA) and messenger RNA (mRNA), contributes to the development of HCC. Exosomes mediate communication between both HCC and non-HCC cells involved in tumor-associated cells, and several molecules are implicated in exosome biogenesis. Exosomes may be potential diagnostic biomarkers for early-stage HCC. Exosomal proteins, miRNAs and lncRNAs could provide new biomarker information for HCC. Exosomes are also potential targets for the treatment of HCC. Notably, further efforts are required in this field. We reviewed recent literature and demonstrated how useful exosomes are for diagnosing patients with HCC, treating patients with HCC and predicting the prognosis of HCC patients.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Exosomes and circular RNAs: promising partners in hepatocellular carcinoma from bench to bedside
    Mengyuan Hu
    Xue Li
    Zhenluo Jiang
    Qing Xia
    Yaoren Hu
    Junming Guo
    Liyun Fu
    [J]. Discover Oncology, 14
  • [2] Exosomes and circular RNAs: promising partners in hepatocellular carcinoma from bench to bedside
    Hu, Mengyuan
    Li, Xue
    Jiang, Zhenluo
    Xia, Qing
    Hu, Yaoren
    Guo, Junming
    Fu, Liyun
    [J]. DISCOVER ONCOLOGY, 2023, 14 (01)
  • [3] Ferroptosis in hepatocellular carcinoma: from bench to bedside
    Tang, Daolin
    Kroemer, Guido
    Kang, Rui
    [J]. HEPATOLOGY, 2024, 80 (03) : 721 - 739
  • [4] Exosomes - From Bench to Bedside
    Ludwig, A. K.
    Kordelas, L.
    Rebmann, V
    Radtke, S.
    Felderhoff-Mueser, U.
    Horn, P. A.
    Beelen, D.
    Giebel, B.
    [J]. KLINISCHE PADIATRIE, 2012, 224 (07): : 477 - 477
  • [5] Deciphering Hepatocellular Carcinoma: From Bench to Bedside and Back
    Goessling, Wolfram
    [J]. GASTROENTEROLOGY, 2009, 137 (03) : 786 - 788
  • [6] Management of hepatocellular carcinoma: from bench to bedside and beyond
    Cheung, Tan To
    [J]. TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 4
  • [7] New insights in hepatocellular carcinoma: from bench to bedside
    De Minicis, Samuele
    Marzioni, Marco
    Benedetti, Antonio
    Svegliati-Baroni, Gianluca
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2013, 1 (02)
  • [8] Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside
    Aghemo, Alessio
    Colombo, Massimo
    [J]. SEMINARS IN IMMUNOPATHOLOGY, 2013, 35 (01) : 111 - 120
  • [9] Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside
    Siracusano, Gabriel
    Tagliamonte, Maria
    Buonaguro, Luigi
    Lopalco, Lucia
    [J]. VACCINES, 2020, 8 (01)